
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis Inc. is positioned for significant financial growth, with forecasts indicating total revenue could reach $43 million by FY26, reflecting a 24% increase due to heightened adoption of new systems and continued catheter usage. The company demonstrated robust performance in its second quarter, achieving $8.8 million in revenue, marking a remarkable 95% year-over-year increase and an 18% sequential rise. Additionally, with strong advancements in regulatory approvals for its next-gen robotic systems and catheters, as well as a reaffirmation of double-digit revenue growth for 2025, Stereotaxis is set to capitalize on its expanding portfolio and enhance disposable revenue streams.
Bears say
Stereotaxis Inc.'s financial outlook is challenged by several fundamental issues, including a net loss of $3.8 million, indicative of ongoing profitability struggles, as well as reliance on a single revenue stream from Disposables, service, and accessories. The company faces significant risks such as delays in product approvals, supply chain issues with current catheters, and potential adverse effects from changes in reimbursement rates, which could undermine revenue projections. Additionally, Stereotaxis has only two years of cash runway remaining and may need to seek further financing to sustain operations and facilitate growth, which adds to the uncertainty surrounding its financial stability.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares